FIELD: chemistry.
SUBSTANCE: present invention is related to compounds of formula I , which are inhibitors of p38 kinase and may be used in medicine, where A represents N or N+O-; R1 represents phenyl or heterocyclyl; R2 represents heterocyclyl; R3 represents H, carbocyclic radical, aryl or heterocyclyl; R4 represents H, Ra, halogen, -ORa', -CN, -CONRa'Ra', -NRa'Ra', -NRa'CORa' or -NRa'CO2Ra; R5 may be connected to any of nitrogens of pyrazole ring of compound in formula I and represents H, alkyl, alkenyl, carbocyclic radical, aryl or heterocyclyl; Ra independently represents alkyl, carbocyclic radical, aryl or heterocyclyl; each Ra' independently represents H or Ra.
EFFECT: preparation of new biologically active compounds.
41 cl, 299 ex, 15 tbl
Title | Year | Author | Number |
---|---|---|---|
PYRIDOPYRIMIDINONE DERIVATIVES AND USE THEREOF AS AROMATIC HYDROCARBON RECEPTOR MODULATORS | 2021 |
|
RU2818954C1 |
ANTAGONISTS OF CHEMOKINE RECEPTORS | 2013 |
|
RU2646762C2 |
MKK4 PROTEIN KINASE INHIBITORS FOR STIMULATION OF LIVER REGENERATION OR REDUCTION OR PREVENTION OF HEPATOCYTE DEATH | 2019 |
|
RU2788000C2 |
ETHYLENEDIAMINE DERIVATIVES AND FXa INHIBITOR AND ANTICOAGULANT COMPRISING THEREOF | 2001 |
|
RU2268259C2 |
HETEROCYCLIC COMPOUNDS | 2005 |
|
RU2390522C2 |
PYRAZOLO[1,5-A]PYRIDINES AND PHARMACEUTICAL AGENTS CONTAINING THE SAME | 2002 |
|
RU2308457C2 |
SUBSTITUTED 2H-PYRAZOLE DERIVATIVE | 2016 |
|
RU2722363C2 |
PYRAZOLE DERIVATIVES | 2004 |
|
RU2332412C2 |
INHIBITOR COMPOUNDS | 2013 |
|
RU2673079C2 |
DIAZOLE LACTAMS | 2013 |
|
RU2666730C2 |
Authors
Dates
2009-06-27—Published
2004-02-27—Filed